Stock Taper
Latest 13F filing data - Q1 2024
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Alnylam Pharmaceuticals, Inc. | ALNY | 200 | $29.89K |
Eli Lilly and Company | LLY | 9.2K | $7.16M |
ICON Public Limited Company | ICLR | 14.8K | $4.97M |
Thermo Fisher Scientific Inc. | TMO | 18.4K | $10.69M |
Danaher Corporation | DHR | 108.7K | $27.14M |
Agios Pharmaceuticals, Inc. | AGIO | 113.1K | $3.31M |
Biohaven Ltd. | BHVN | 118.38K | $6.47M |
enGene Holdings Inc. | ENGN | 120.29K | $2.04M |
Metagenomi, Inc. Common Stock | MGX | 133.33K | $1.41M |
Zymeworks Inc. | ZYME | 145.58K | $1.53M |
Janux Therapeutics, Inc. | JANX | 193.3K | $7.28M |
Structure Therapeutics Inc. | GPCR | 205.17K | $8.79M |
Denali Therapeutics Inc. | DNLI | 209.61K | $4.3M |
Immunome, Inc. | IMNM | 262.28K | $6.47M |
Surrozen, Inc. | SRZNW | 384.57K | $12.5K |
Kiniksa Pharmaceuticals International, plc | KNSA | 400.44K | $7.9M |
Roivant Sciences Ltd. | ROIV | 454.77K | $4.79M |
Stevanato Group S.p.A. | STVN | 550K | $17.66M |
ArriVent BioPharma, Inc. | AVBP | 555.55K | $9.92M |
BridgeBio Pharma, Inc. | BBIO | 612.06K | $18.92M |